Jenscare Scientific Co (HKSE:09877) GF Score: 33/100 (As of Aug. 18, 2026) — 200% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:09877 Jenscare Scientific Co Ltd HKSE:09877
33 GF Score
Price HK$7.49
! 4 Warning Signs
View Full Analysis

What is Jenscare Scientific Co GF Score?

Jenscare Scientific Co HKSE:09877 +0.60% 33 GF Score is 33 as of Aug. 18, 2026, which is 200% above its 10-year median of 11.00. GuruFocus rates HKSE:09877 with a GF Score™ of 33/100. The stock has 4 warning signs investors should review.

Jenscare Scientific Co has the GF Score of 33, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 8/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 8/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Jenscare Scientific Co might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Jenscare Scientific Co  (HKSE:09877) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.


Jenscare Scientific Co GF Score Related Terms


HKSE:09877 vs ABT, SYK, MDT: GF Score Comparison

For the Medical Devices subindustry, Jenscare Scientific Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jenscare Scientific Co GF Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jenscare Scientific Co's GF Score distribution charts can be found below:

* The bar in red indicates where Jenscare Scientific Co's GF Score falls into.


HKSE:09877
33GF Score
Jenscare Scientific Co Ltd HKSE:09877
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 33 mean?
Jenscare Scientific Co (HKSE:09877) has a GF Score of 33 as of Aug. 18, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Jenscare Scientific Co and its competitors. This is 200% above median its historical median of 11.00. Over the past decade, Jenscare Scientific Co's GF Score has ranged from 4.00 to 34.00.
Is Jenscare Scientific Co's GF Score too high?
Jenscare Scientific Co's current GF Score of 33 is 200% above median its 10-year median of 11.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 34.00. Overall, Jenscare Scientific Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Jenscare Scientific Co's GF Score compare to ABT and SYK?
Jenscare Scientific Co's GF Score of 33 can be compared against companies in the Medical Devices & Instruments industry. Historically, Jenscare Scientific Co's own GF Score has ranged from 4.00 to 34.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Jenscare Scientific Co and its competitors. Jenscare Scientific Co's current GF Score is 33, which is 200% above median its own 10-year median of 11.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jenscare Scientific Co stock overvalued right now?
Jenscare Scientific Co (HKSE:09877) has a current GF Score of 33. The current GF Score is 33, which is 200% above median its 10-year median of 11.00. Jenscare Scientific Co's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Jenscare Scientific Co (HKSE:09877), the current GF Score is 33 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jenscare Scientific Co Business Description

Address No. 777 Binhai 4th Road, Block 5, B Area, Hangzhou Bay New Area, Zhejiang Province, Ningbo, CHN
Jenscare Scientific Co Ltd is engaged in the manufacturing, research, and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. Geographically, the company generates the majority of its revenue from the Chinese mainland.
33GF Score

Get the complete analysis for HKSE:09877

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$7.49
Price